buprenorphine transdermal system (buprenorphine)

**Product type:** Human Prescription Drug

**Active ingredient:** BUPRENORPHINE

**Strength:** 15 ug/h

**Dosage form:** Patch, Extended Release

**Route:** Transdermal

**Labeler:** Alvogen Inc.

**Marketing category:** ANDA (ANDA207490)

**Pharmacologic class:** Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]

**DEA schedule:** CIII